Paper6940195
Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.
Forssen EA and 1 other. Proc Natl Acad Sci U S A, 1981. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. Papers, record 6940195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6940195
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Heart | Major topic |
| Liposomes | Major topic |
| Animals | |
| Anions | |
| Body Weight | |
| Injections, Intravenous | |
| Leukemia L1210 | |
| Leukemia P388 | |
| Mice |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA-21271 | NCI NIH HHS | United States | R01CA021271 | PubMed and NIH |
Source NIH RePORTER
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4353012 | A clinicopathologic analysis of adriamycin cardiotoxicity. | Cancer | 1973 | https://conductscience.org/library/papers/4353012 | PubMed |
| 2 | 7471083 | Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo. | Cancer Res | 1980 | https://conductscience.org/library/papers/7471083 | PubMed |
| 3 | 1159813 | Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity. | J Natl Cancer Inst | 1975 | https://conductscience.org/library/papers/1159813 | PubMed |
| 4 | 1277204 | Delayed and progressive myocardial lesions after adriamycin administration in the rabbit. | Cancer Res | 1976 | https://conductscience.org/library/papers/1277204 | PubMed |
| 5 | 9083 | Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions. | Biochem Biophys Res Commun | 1976 | https://conductscience.org/library/papers/9083 | PubMed |
| 6 | 822941 | Cardiotoxicity of adriamycin and related anthracyclines. | Cancer Treat Rev | 1976 | https://conductscience.org/library/papers/822941 | PubMed |
| 7 | 793635 | New aspects of liposomes. | Biochim Biophys Acta | 1976 | https://conductscience.org/library/papers/793635 | PubMed |
| 8 | 872096 | Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. | Cancer Res | 1977 | https://conductscience.org/library/papers/872096 | PubMed |
| 9 | 909284 | Subacute cardiotoxicity of adriamycin in the rat: biochemical and ultrastructural investigations. | Lab Invest | 1977 | https://conductscience.org/library/papers/909284 | PubMed |
| 10 | 412241 | Membrane actions of daunorubicin in mammalian erythrocytes. | Res Commun Chem Pathol Pharmacol | 1977 | https://conductscience.org/library/papers/412241 | PubMed |
| 11 | 619903 | Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin. | Biochem Pharmacol | 1978 | https://conductscience.org/library/papers/619903 | PubMed |
| 12 | 565963 | Ultrastructural alterations of atrial myocardium induced by adriamycin in chronically treated animals. | Tumori | 1978 | https://conductscience.org/library/papers/565963 | PubMed |
| 13 | 279290 | Liposomes as lysosomotropic carriers. | Ann N Y Acad Sci | 1978 | https://conductscience.org/library/papers/279290 | PubMed |
| 14 | 279296 | Mechanisms of reduction of antitumor drug toxicity by liposome encapsulation. | Ann N Y Acad Sci | 1978 | https://conductscience.org/library/papers/279296 | PubMed |
| 15 | 421223 | Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia. | Cancer Res | 1979 | https://conductscience.org/library/papers/421223 | PubMed |
| 16 | 455325 | Experimental evaluation of anthracycline analogs. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/455325 | PubMed |
| 17 | 291473 | Sudden death during doxorubicin administration. | Cancer | 1979 | https://conductscience.org/library/papers/291473 | PubMed |
| 18 | 526304 | In vitro and in vivo studies with adriamycin liposomes. | Biochem Biophys Res Commun | 1979 | https://conductscience.org/library/papers/526304 | PubMed |
| 19 | 526920 | Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/526920 | PubMed |
| 20 | 7370991 | Liposomal protection of adriamycin-induced cardiotoxicity in mice. | Cancer Res | 1980 | https://conductscience.org/library/papers/7370991 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41252081 | TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16). | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/41252081 | PubMed |
| 39885941 | Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective. | BMJ Oncol | 2025 | https://conductscience.org/library/papers/39885941 | PubMed |
| 39621070 | The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models. | Basic Res Cardiol | 2025 | https://conductscience.org/library/papers/39621070 | PubMed |
| 38786467 | Effects of Anionic Liposome Delivery of All-Trans-Retinoic Acid on Neuroblastoma Cell Differentiation. | Biomimetics (Basel) | 2024 | https://conductscience.org/library/papers/38786467 | PubMed |
| 37047585 | Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047585 | PubMed |
| 36771161 | A Review of Different Types of Liposomes and Their Advancements as a Form of Gene Therapy Treatment for Breast Cancer. | Molecules | 2023 | https://conductscience.org/library/papers/36771161 | PubMed |
| 34149423 | Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34149423 | PubMed |
| 32104444 | Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy. | Asian J Pharm Sci | 2019 | https://conductscience.org/library/papers/32104444 | PubMed |
| 30504893 | Identification of Immune Signatures of Novel Adjuvant Formulations Using Machine Learning. | Sci Rep | 2018 | https://conductscience.org/library/papers/30504893 | PubMed |
| 25258527 | Nanopharmaceuticals (part 1): products on the market. | Int J Nanomedicine | 2014 | https://conductscience.org/library/papers/25258527 | PubMed |
| 24277284 | Stability of liposomes on storage: freeze dried, frozen or as an aqueous dispersion. | Pharm Res | 1984 | https://conductscience.org/library/papers/24277284 | PubMed |
| 11718259 | High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin. | J Neurooncol | 2001 | https://conductscience.org/library/papers/11718259 | PubMed |
| 10698235 | Cardiotoxicity of doxorubicin and other anthracycline derivatives. | J Nucl Cardiol | 2000 | https://conductscience.org/library/papers/10698235 | PubMed |
| 9063678 | Diversity of lipid-based polyene formulations and their behavior in biological systems. | Eur J Clin Microbiol Infect Dis | 1997 | https://conductscience.org/library/papers/9063678 | PubMed |
| 8855969 | Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8855969 | PubMed |
| 8679456 | An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8679456 | PubMed |
| 8500223 | Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8500223 | PubMed |
| 8269584 | Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8269584 | PubMed |
| 8200855 | Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/8200855 | PubMed |
| 7950152 | Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences. | Clin Investig | 1994 | https://conductscience.org/library/papers/7950152 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6940195
GET https://conductscience.org/api/papers/v1/6940195/references?page=2